相关产品推荐更多 >

TIGIT/TIGIT蛋白Recombinant Human T-cell immunoreceptor with Ig and ITIM domains (TIGIT)重组蛋白V-set and immunoglobulin domain-containing protein 9 V-set and transmembrane domain-containing protein 3蛋白
¥1836
Recombinant-Human-Transmembrane-protein-107TMEM107Transmembrane protein 107
¥10024
apaLIM/apaLIM蛋白Recombinant Acetobacter pasteurianus Modification methylase ApaLI (apaLIM)重组蛋白Cytosine-specific methyltransferase ApaLI蛋白
¥2616
Recombinant-Human-ProtrudinZFYVE27Protrudin Alternative name(s): Zinc finger FYVE domain-containing protein 27
¥12432
KMT2E/KMT2E蛋白/Myeloid/lymphoid or mixed-lineage leukemia protein 5蛋白/Recombinant Human Inactive histone-lysine N-methyltransferase 2E (KMT2E), partial重组蛋白
¥69
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
- 保质期:
Generally, the shelf life of liquid form is 6 months at -20℃/-80℃. The shelf life of lyophilized form is 12 months at -20℃/-80℃.
- 英文名:
Recombinant Human Programmed cell death protein 1 (PDCD1), partial (Active)
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 规格:
1mg/100μg/20μg
| 规格: | 1mg | 产品价格: | ¥22200.0 |
|---|---|---|---|
| 规格: | 100μg | 产品价格: | ¥2568.0 |
| 规格: | 20μg | 产品价格: | ¥1368.0 |
纯度:
Greater than 95% as determined by SDS-PAGE.基因名:
PDCD1Uniprot No.:
Q15116别名:
(Protein PD-1) (hPD-1) (CD279)种属:
Homo sapiens (Human)蛋白长度:
Partial来源:
Mammalian cell分子量:
18.2 kDa表达区域:
25-167aa氨基酸序列:
LDSPDRPWN_P_PTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQ蛋白标签:
C-terminal 6xHis-tagged产品提供形式:
Lyophilized powder缓冲液:
Lyophilized from a 0.2 μm filtered 20 mM Tris-HCl, 0.5 M NaCl, 6% Trehalose, pH 8.0货期:
3-7 business days注意事项:
Repeated freezing and thawing is not recommended. Store working aliquots at 4℃ for up to one week.功能:
Inhibitory cell surface receptor involved in the regulation of T-cell function during immunity and tolerance. Upon ligand binding, inhibits T-cell effector functions in an antigen-specific manner. Possible cell death inducer, in association with other factors.内毒素:
Less than 1.0 EU/ug as determined by LAL method.SDS-PAGE:
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.LC-MS Image Description/Western Blot:
/Product types:
Active Protein & In Stock ProteinBiological_Activity:
①Measured by its binding ability in a functional ELISA. Immobilized PD-1 at 2 μg/ml can bind Anti-PD-1 recombinant antibody, the EC50 of human PD-1 protein is 6.087-7.854 ng/ml. ②Measured by its binding ability in a functional ELISA. Immobilized PD-1 at 2 μg/ml can bind Nivolumab, the EC50 of human PD-1 protein is 9.713-12.39 ng/ml.Research Areas:
CancerReconstitution:
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.Reference:
/Function:
/风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Induction of Programmed Cell Death with an Antisense Bcl-2 Oligonucleotide
(3 ,4 ). Therefore, genetic manipulation of PCD regulatory genes may restore the altered homeostasis in these cells and permit these genetically damaged cells to enter PCD.A known regulator of the PCD pathway is Bcl-2, a protein capable of suppressing cell death
has been reported in a wide range of human malignancies, including non-small cell lung cancer (NSCLC) (4 -6) . One early consequence of the binding of EGFR ligands (EGF or transforming growth factor-α [TGF-α]) to EGFR is the induction of receptor dimerization
Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes
that enhance cancer cellular proliferation, metastases, genomic instability, enhance drug resistance, and oppose programmed cell death mechanisms is yet unknown.
技术资料暂无技术资料 索取技术资料





